Araceli Garcia-Martinez
Overview
Explore the profile of Araceli Garcia-Martinez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
171
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Olza I, Quintela O, Garcia-Martinez A
Int J Environ Res Public Health
. 2025 Jan;
22(1).
PMID: 39857455
Obstetric violence during pregnancy and childbirth is unfortunately a major problem throughout the world. Neuroleptanalgesia is a classic form of analgesia which consists in administering analgesics and neuroleptics, such as...
2.
Larriba E, de Juan Romero C, Garcia-Martinez A, Quintanar T, Rodriguez-Lescure A, Soto J, et al.
Comput Biol Med
. 2024 Jul;
179:108833.
PMID: 38981212
This study provides a comprehensive perspective on the deregulated pathways and impaired biological functions prevalent in human glioblastoma (GBM). In order to characterize differences in gene expression between individuals diagnosed...
3.
Sampedro-Nunez M, Herrera-Martinez A, Ibanez-Costa A, Rivero-Cortes E, Venegas E, Robledo M, et al.
Eur J Endocrinol
. 2024 May;
190(6):421-433.
PMID: 38701338
Introduction: Growth hormone (GH)-secreting pituitary tumors (GHomas) are the most common acromegaly cause. At diagnosis, most of them are macroadenomas, and up to 56% display cavernous sinus invasion. Biomarker assessment...
4.
Gil J, Marques-Pamies M, Sampedro M, Webb S, Serra G, Salinas I, et al.
Sci Rep
. 2022 Jun;
12(1):8979.
PMID: 35643771
Predicting which acromegaly patients could benefit from somatostatin receptor ligands (SRL) is a must for personalized medicine. Although many biomarkers linked to SRL response have been identified, there is no...
5.
Moreno-Moreno P, Ibanez-Costa A, Venegas-Moreno E, Fuentes-Fayos A, Alhambra-Exposito M, Fajardo-Montanana C, et al.
J Clin Endocrinol Metab
. 2022 Mar;
107(7):e2938-e2951.
PMID: 35312002
Context: Adrenocorticotropin (ACTH)-secreting pituitary tumors (ACTHomas) are associated with severe comorbidities and increased mortality. Current treatments mainly focus on remission and prevention of persistent disease and recurrence. However, there are...
6.
Gil J, Marques-Pamies M, Valassi E, Garcia-Martinez A, Serra G, Hostalot C, et al.
Biomedicines
. 2022 Feb;
10(2).
PMID: 35203668
Acromegaly is caused by excess growth hormone (GH) produced by a pituitary tumor. First-generation somatostatin receptor ligands (SRLs) are the first-line treatment. Several studies have linked E-cadherin loss and epithelial-mesenchymal...
7.
Garcia-Martinez A, Perez-Balaguer A, Ortiz-Martinez F, Pomares-Navarro E, Sanmartin E, Garcia-Escolano M, et al.
Pathol Res Pract
. 2021 May;
223:153478.
PMID: 34022683
Purpose: Hedgehog (Hh) signaling is a crucial developmental regulatory pathway recognized as a primary oncogenesis driver in various human cancers. However, its role in breast carcinoma (BC) has been underexplored....
8.
Silva-Ortega S, Garcia-Martinez A, Niveiro de Jaime M, Torregrosa M, Abarca J, Monjas I, et al.
Hum Pathol
. 2020 Dec;
110:20-30.
PMID: 33321163
The immunohistochemistry (IHC) characterization of pituitary transcription factors (PTFs) PIT1, TPIT, and SF1, which enable the identification of three different adenohypophyseal cell lines, has been incorporated into the latest classification...
9.
Gil J, Marques-Pamies M, Jorda M, Fajardo-Montanana C, Garcia-Martinez A, Sampedro M, et al.
Clin Endocrinol (Oxf)
. 2020 Sep;
94(5):811-819.
PMID: 32978826
Objective: Large somatotrophic adenomas depict poor response to somatostatin receptor ligands (SRLs). Debulking has shown to enhance SRLs effect in some but not all cases and tumour volume reduction has...
10.
Garcia-Martinez A, Fuentes-Fayos A, Fajardo C, Lamas C, Camara R, Lopez-Munoz B, et al.
J Clin Med
. 2020 Jun;
9(6).
PMID: 32545591
The potential role of miRNAs in the silencing mechanisms of pituitary neuroendocrine tumors (PitNETs) has not been addressed. The aim of the present study was to evaluate the expression levels...